These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 30183070)

  • 1. The use of direct oral anticoagulants in chronic kidney disease.
    Parker K; Thachil J
    Br J Haematol; 2018 Oct; 183(2):170-184. PubMed ID: 30183070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Managing the perioperative patient on direct oral anticoagulants.
    Leitch J; van Vlymen J
    Can J Anaesth; 2017 Jun; 64(6):656-672. PubMed ID: 28429198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insight into the perioperative management of direct oral anticoagulants: concerns and considerations.
    Ibrahim A; Walsh LG; Algaali M; Satti Z; Kiernan TJ; Yan BP
    Expert Opin Pharmacother; 2019 Mar; 20(4):465-472. PubMed ID: 30521411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct oral anticoagulants use in elderly patients with non valvular atrial fibrillation: state of evidence.
    Benedetti G; Neccia M; Agati L
    Minerva Cardioangiol; 2018 Jun; 66(3):301-313. PubMed ID: 29125269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Direct Oral Anticoagulants in Special Populations.
    Li A; Lopes RD; Garcia DA
    Hematol Oncol Clin North Am; 2016 Oct; 30(5):1053-71. PubMed ID: 27637307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal Function and Direct Oral Anticoagulant Treatment for Venous Thromboembolism.
    Fanikos J; Burnett AE; Mahan CE; Dobesh PP
    Am J Med; 2017 Oct; 130(10):1137-1143. PubMed ID: 28687262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Practical aspects of therapy with new oral anticoagulants in patients with impaired renal function].
    Kropacheva ES
    Kardiologiia; 2014; 54(4):78-83. PubMed ID: 25177789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent evidence for direct oral anticoagulants in chronic kidney disease.
    Ha JT; Badve SV; Jun M
    Curr Opin Nephrol Hypertens; 2019 May; 28(3):251-261. PubMed ID: 30789840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticoagulant therapy in renal insufficiency theme: Anticoagulation in complex situations.
    Parks AL; Stevens SM; Woller SC
    Thromb Res; 2024 Sep; 241():109097. PubMed ID: 39094333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stroke prevention in atrial fibrillation patients with chronic kidney disease.
    Hart RG; Eikelboom JW; Brimble KS; McMurtry MS; Ingram AJ
    Can J Cardiol; 2013 Jul; 29(7 Suppl):S71-8. PubMed ID: 23790601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DOAC use in patients with chronic kidney disease.
    Kcükköylü S; Rump LC
    Hamostaseologie; 2017; 37(4):286-294. PubMed ID: 29582930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemorragic and thromboembolic risk in CKD patients with non valvular atrial fibrillation: Do we need a novel risk score calculator?
    Ravera M; Bussalino E; Paoletti E; Bellasi A; Di Lullo L; Fusaro M
    Int J Cardiol; 2019 Jan; 274():179-185. PubMed ID: 30177235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Direct oral anticoagulants (DOAC) : practical guidance for daily prescription].
    Robert-Ebadi H; Fontana P; Boehlen F; Righini M
    Rev Med Suisse; 2016 Dec; 12(542):2102-2112. PubMed ID: 28700163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current and developing strategies for monitoring and reversing direct oral anticoagulants in patients with non-valvular atrial fibrillation.
    Sarma A; Giugliano RP
    Hosp Pract (1995); 2015; 43(5):258-67. PubMed ID: 26559852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. When and how to use direct oral anticoagulants in patients with advanced chronic liver disease?
    De Maria C; Galante A; Fasoli A; De Gottardi A
    Curr Opin Pharmacol; 2021 Oct; 60():111-116. PubMed ID: 34403992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Creatinine Clearance Is Not Equal to Glomerular Filtration Rate and Cockcroft-Gault Equation Is Not Equal to CKD-EPI Collaboration Equation.
    Fernandez-Prado R; Castillo-Rodriguez E; Velez-Arribas FJ; Gracia-Iguacel C; Ortiz A
    Am J Med; 2016 Dec; 129(12):1259-1263. PubMed ID: 27612441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticoagulation in chronic kidney disease: current status and future perspectives.
    Jones A; Swan D; Lisman T; Barnes GD; Thachil J
    J Thromb Haemost; 2024 Feb; 22(2):323-336. PubMed ID: 37778512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Updates in periprocedural management of direct oral anticoagulants.
    Tao J; Oprea AD
    Curr Opin Anaesthesiol; 2020 Jun; 33(3):423-431. PubMed ID: 32371643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonvitamin K-dependent oral anticoagulants (NOACs) in chronic kidney disease patients with atrial fibrillation.
    Di Lullo L; Ronco C; Cozzolino M; Russo D; Russo L; Di Iorio B; De Pascalis A; Barbera V; Galliani M; Vitaliano E; Campana C; Santoboni F; Bellasi A
    Thromb Res; 2017 Jul; 155():38-47. PubMed ID: 28482261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is it reasonable to use a lower DOAC dose in some patients with VTE? NO.
    Dentali F; Fantoni C
    Intern Emerg Med; 2017 Aug; 12(5):565-567. PubMed ID: 28656545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.